Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 9/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.39 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22278278 | 0.82 | ERN1 (0.57) | ERN1MAPTALDH1A1GAAHPGD | |
| SCHEMBL2853452 | 0.80 | ALDH1A1 (0.42) | ERN1MAPTALDH1A1LMNA | |
| SCHEMBL6561561 | 0.79 | TRIM24 (0.57) | MAPTALDH1A1GAAHPGDMEN1 | |
| SCHEMBL22266039 | 0.77 | TUBB1 (0.46) | MAPTALDH1A1GAAHPGDMEN1 | |
| SCHEMBL3818350 | 0.76 | MAPT (0.47) | MAPTALDH1A1GAAHPGDMEN1 | |
| SCHEMBL663655 | 0.76 | CA12 (0.42) | MAPTALDH1A1GAAHPGDMEN1 | |
| SCHEMBL13836564 | 0.76 | CA12 (0.42) | MAPTALDH1A1GAAHPGDMEN1 | |
| SCHEMBL16015475 | 0.75 | SLC5A1 (0.46) | MAPTALDH1A1GAAHPGDMEN1 | |
| SCHEMBL18984966 | 0.75 | SLC5A1 (0.46) | MAPTALDH1A1GAAHPGDMEN1 | |
| SCHEMBL22779337 | 0.75 | CA12 (0.44) | MAPTALDH1A1GAAHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1988954-B | Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid | ENDURA SPA | 2012-01-18 | — | — | CN | disclosed |
| US-20100204038-A1 | Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid | CARLONI SILVIA | 2010-08-12 | — | — | US | disclosed |
| EP-1765496-B1 | CATALYSTS BASED ON COPPER COMPLEXES FOR THE SYNTHESIS OF OPTICALLY ACTIVE CHRYSANTHEMIC ACID | ENDURA SPA (IT) | 2010-07-14 | — | — | EP | disclosed |
| US-7723539-B2 | Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid | ENDURA S.P.A. (IT) | 2010-05-25 | — | — | US | disclosed |
| US-20080021237-A1 | Catalysts Based on Metal Complexes for the Synthesis of Optically Active Chrysanthemic Acid | ENDURA S.P.A. (IT) | 2008-01-24 | — | — | US | disclosed |
| CN-1988954-A | Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid | ENDURA SPA (IT) | 2007-06-27 | — | — | CN | disclosed |
| EP-1765496-A1 | CATALYSTS BASED ON METAL COMPLEXES FOR THE SYNTHESIS OF OPTICALLY ACTIVE CHRYSANTHEMIC ACID | ENDURA S.p.A. (IT) | 2007-03-28 | — | — | EP | disclosed |
| WO-2005123254-A1 | CATALYSTS BASED ON METAL COMPLEXES FOR THE SYNTHESIS OF OPTICALLY ACTIVE CHRYSANTHEMIC ACID | ENDURA S.P.A. (IT) | 2005-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021237-A1 | Catalysts Based on Metal Complexes for the Synthesis of Optically Active Chrysanthemic Acid | SCO2, ME1, ME3 | ERN1 4286/4885MAPT 1247/4885ALDH1A1 1925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.